Tolerability Issues During Long-Term Treatment with Antidepressants
The DOI matches its Crossref record; 101 of the 103 references it cites were found in a registry or an index.
Abstract
Depressive disorders are highly prevalent in the general population. Long-term treatment with antidepressants consolidates the improvement obtained during the acute phase of the treatment and prevents relapses and recurrences of the disorder. On the other hand, there is growing evidence that antidepressant side effects may limit patients' quality of life and social functioning, as well as affect patients' health and treatment adherence. Most studies concerning antidepressant treatment have focused on short-term tolerability, ignoring both early-onset persistent side effects and late-onset side effects that are reported during long-term treatment. Nevertheless, these long-term treatment side effects are likely to have a dramatic impact on patient outcome and treatment adherence. Common long-term side effects of antidepressants are weight gain, sexual dysfunction, sleep disturbances, fatigue, apathy, and cognitive impairment (e.g., working memory dysfunction). Usual strategies for the management of these long-term side effects are: changing drug daily schedule, various augmentation therapies, antidepressant switches, drug-holidays, and dose tapering, with the latter two strategies being strongly discouraged on the basis of concerns that patients' depressive episodes may return. Selective serotonin reuptake inhibitors (SSRIs) and atypical antidepressants (e.g., venlafaxine, bupropion, and nefazodone) show a relatively favorable short-term as well as long-term tolerability compared with older drugs (e.g., tricyclics and monoamine oxidase inhibitors). Therefore, clinicians are likely to prefer them in usual practice, especially among patients requiring maintenance treatment. The present review focuses on management of long-term side effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although widely used and efficacious [8–10], SRI use long-term is associated with adverse side effects [11–14]”
From Unified protocol for the discontinuation of long-term serotonin reuptake inhibitors in obsessive compulsive disorder: Study protocol and methods (2018) · cites this paper as [12]
Citations
Cites
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.7.979 · Cited by 1,485
Three-Year Outcomes for Maintenance Therapies in Recurrent Depression
Frank, E. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810240013002 · Cited by 1,297
(1994) · PharmacoResources · doi:10.1007/bf03289581 · Cited by 974
Anderson, I. M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00092-0 · Cited by 940
Recurrence after recovery from major depressive disorder during 15 years of observational follow-up
Mueller, T. I., Leon, A. C., Keller, M. B., Solomon, D. A., Endicott, J., Coryell, W., Warshaw, M., & Maser, J. D. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.7.1000 · Cited by 897 · cited 1×
“Patients who are prone to severe and life-threatening depressive episodes or to chronic/recurrent depressive episodes, for example, may require indefinite antidepressant treatment, eventually combined with other treatment modalities, such as cognitive behavioral therapy (15,16).”
BackgroundThe Role of the Primary Care Physician in Patientsʼ Adherence to Antidepressant Therapy
LIN, E. H. B., KORFF, M. V., KATON, W., BUSH, T., SIMON, G. E., WALKER, E., & ROBINSON, P. (1995) · Medical Care · doi:10.1097/00005650-199501000-00006 · Cited by 587
Adequacy and Duration of Antidepressant Treatment in Primary Care
Katon, W., Von Korff, M., Lin, E., Bush, T., & Ormel, J. (1992) · Medical Care · doi:10.1097/00005650-199201000-00007 · Cited by 513
Montejo-gonzàlez, A. L., Llorca, G., Izquierdo, J. A., Ledesma, A., Bousono, M., Calcedo, A., Carrasco, J. L., Ciudad, J., Daniel, E., De LA Gandara, J., et al. (1997) · Journal of Sex & Marital Therapy · doi:10.1080/00926239708403923 · Cited by 505 · cited 2×
“Sexual side effects appear to be dose-related and may be improved by a reduction in dosage (59).”
BackgroundMontejo, A. L., Llorca, G., Izquierdo, J. A., & Rico‐Villademoros, F. (2001) · PubMed · Cited by 460
Weight gain and antidepressants.
D, M. F. M. (2000) · PubMed · Cited by 388
Self-citation
Cited by
Otte, C., Gold, S. M., Penninx, B. W., Pariante, C. M., Etkin, A., Fava, M., Mohr, D. C., & Schatzberg, A. F. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.65 · Cited by 2,269
A meta-analysis of cognitive deficits in first-episode Major Depressive Disorder
Lee, R. S. C., Hermens, D. F., Porter, M. A., & Redoblado-Hodge, M. A. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.10.023 · Cited by 737
“First-generation medications, such as tricyclic antidepressants (Cassano and Fava, 2004), and first-generation antipsychotics, such as haloperidol, have been shown to have negative effects on cognition (Jerrell and Ramirez, 2008).”
BackgroundMcMahon, F. J., Buervenich, S., Charney, D., Lipsky, R., Rush, A. J., Wilson, A. F., Sorant, A. J. M., Papanicolaou, G. J., Laje, G., Fava, M., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/503820 · Cited by 474
“Medication tolerability comprises an individual’s objective and perceived side-effect burden and typically increases over time and with response to treatment.(19) Since failure to consider tolerability could lead to misclassification of intolerant patients as nonresponders, we scored all subjects as tolerant, probably…”
BackgroundLeptin: A potential novel antidepressant
Lu, X.-Y., Kim, C. S., Frazer, A., & Zhang, W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508901103 · Cited by 446
Nutrition and Depression: Implications for Improving Mental Health Among Childbearing-Aged Women
Bodnar, L. M., & Wisner, K. L. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.009 · Cited by 351
Metadata
- Authors
- Cassano, P., & Fava, M.
- Affiliations
- Massachusetts General Hospital (US)
- ORCID
- Cassano, Paolo
- Venue
- Annals of Clinical Psychiatry
- Publisher
- SAGE Publications
- Published
- 2004-01
- Volume
- 16
- Issue
- 1
- Pages
- 15-25
- ISSN
- 1040-1237 (ISSN-L)
- 1547-3325
- OpenAlex
- W2154591789
- Cited by
- 154
- References
- 103
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 2 · 2023: 5 · 2022: 6 · 2021: 9 · 2020: 9 · 2019: 8 · 2018: 13 · 2017: 7 · 2016: 6 · 2015: 4 · 2014: 5 · 2013: 7 · 2012: 5
- FWCI
- 5.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- antidepressant tolerability, long-term antidepressant treatment, antidepressant side effects, weight gain, sexual dysfunction, sleep disorders, fatigue, cognitive impairment, working memory, medication adherence, maintenance therapy, selective serotonin reuptake inhibitors, atypical antidepressants, tricyclic antidepressants, monoamine oxidase inhibitors, dose tapering, drug holidays, antidepressant switching, augmentation therapy, relapse prevention
- MeSH terms
- Antidepressive Agents, Cognition Disorders, Depressive Disorder, Fatigue, Humans, Memory Disorders, Sexual Dysfunction, Physiological, Sleep Wake Disorders, Time
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tolerability Issues During Long-Term Treatment with Antidepressants. https://app.cochat.ai/papers/10.1080/10401230490281618
- The paper
- Cassano, P., & Fava, M. (2004). Tolerability Issues During Long-Term Treatment with Antidepressants. Annals of Clinical Psychiatry. https://doi.org/10.1080/10401230490281618
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.